%0 Journal Article
%T Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5
%A Hubert Denise
%A Jacqueline Poot
%A Maribel Jim¨¦nez
%A Audrey Ambit
%A Daland C Herrmann
%A Arno N Vermeulen
%A Graham H Coombs
%A Jeremy C Mottram
%J BMC Molecular Biology
%D 2006
%I BioMed Central
%R 10.1186/1471-2199-7-42
%X We have further focused our studies on LiCPA, the L. infantum homologue to L. mexicana cysteine peptidase CPA. LiCPA was found to share a high percentage of amino acid identity with CPA proteins of other Leishmania species. Two independent LiCPA-deficient promastigote clones (¦¤Licpa) were generated and their phenotype characterised. In contrast to L. mexicana CPA-deficient mutants, both clones of ¦¤Licpa were found to have significantly reduced virulence in vitro and in vivo. Re-expression of just one LiCPA allele (giving ¦¤Licpa::CPA) was sufficient to complement the reduced infectivity of both ¦¤Licpa mutants for human macrophages, which confirms the importance of LiCPA for L. infantum virulence. In contrast, in vivo experiments did not show any virulence recovery of the re-expressor clone ¦¤LicpaC1::CPA compared with the CPA-deficient mutant ¦¤LicpaC1.The data suggest that CPA is not essential for replication of L. infantum promastigotes, but is important for the host-parasite interaction. Further studies will be necessary to elucidate the precise roles that LiCPA plays and why the re-expression of LiCPA in the ¦¤Licpa mutants complemented the gene deletion phenotype only in in vitro and not in in vivo infection of hamsters.Leishmania species are responsible for several pathologies affecting both humans and animals. These parasites are most abundant in developing countries in the Middle East, Asia and South America but also are endemic in the Sub-Mediterranean basin. They have emerged as one of the most important opportunistic agents in AIDS patients [1]. Some cutaneous infections can be resolved and subsequently lead to the development of protection against new infection. These results indicate that immunologic approaches could be effective in preventing or curing infection [2]. However, an effective and safe vaccine has yet to be developed. Efforts towards the development of new cures or vaccines have recently been facilitated by the sequencing of L. major [3], L. br
%U http://www.biomedcentral.com/1471-2199/7/42